We are evaluating the safety and effectiveness of Elacestrant in various combinations for patients with metastatic breast cancer. This study aims to find better treatment options for this condition.
Health conditions and diseases that the clinical trial is designed to study and treat.
Metastatic breast cancer is an advanced form of breast cancer where the cancer cells have spread from the breast to other parts of the body, such as the bones, liver, or lungs. This stage can lead to various symptoms and requires specialized treatment.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
